Literature DB >> 17690928

Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.

C Rieger1, S Geiger, T Herold, C Nickenig, H Ostermann.   

Abstract

A neutropenic patient with acute myeloid leukaemia experienced a breakthrough infection of Trichosporon asahii during posaconazole treatment. After treatment was changed to a combination therapy with voriconazole and liposomal amphotericin B, the infection resolved. Posaconazole works effectively as an antifungal prophylaxis and salvage therapy in rare invasive fungal infections. This case however illustrates that breakthrough infections with T. asahii may occur during posaconazole treatment.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17690928     DOI： 10.1007/s10096-007-0366-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  10 in total

1.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 2.  New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.

Authors:  Elias K Spanakis; George Aperis; Eleftherios Mylonakis
Journal:  Clin Infect Dis       Date:  2006-09-08       Impact factor: 9.079

3.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Authors:  Oliver A Cornely; Johan Maertens; Drew J Winston; John Perfect; Andrew J Ullmann; Thomas J Walsh; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow-Tee Goh; Mario Petrini; Cathy Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

4.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Authors:  Andrew J Ullmann; Jeffrey H Lipton; David H Vesole; Pranatharthi Chandrasekar; Amelia Langston; Stefano R Tarantolo; Hildegard Greinix; Wellington Morais de Azevedo; Vijay Reddy; Navdeep Boparai; Lisa Pedicone; Hernando Patino; Simon Durrant
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

5.  Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.

Authors:  Thomas J Walsh; Issam Raad; Thomas F Patterson; Pranatharthi Chandrasekar; Gerald R Donowitz; Richard Graybill; Reginald E Greene; Ray Hachem; Susan Hadley; Raoul Herbrecht; Amelia Langston; Arnold Louie; Patricia Ribaud; Brahm H Segal; David A Stevens; Jo-Anne H van Burik; Charles S White; Gavin Corcoran; Jagadish Gogate; Gopal Krishna; Lisa Pedicone; Catherine Hardalo; John R Perfect
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

6.  Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.

Authors:  Giovanni Di Bonaventura; Arianna Pompilio; Carla Picciani; Manuela Iezzi; Domenico D'Antonio; Raffaele Piccolomini
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome.

Authors:  Dimitrios P Kontoyiannis; Harrys A Torres; Marlon Chagua; Ray Hachem; Jeffrey J Tarrand; Gerald P Bodey; Issam I Raad
Journal:  Scand J Infect Dis       Date:  2004

8.  Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.

Authors:  V Krcmery; F Mateicka; A Kunová; S Spánik; J Gyarfás; Z Sycová; J Trupl
Journal:  Support Care Cancer       Date:  1999-01       Impact factor: 3.603

9.  Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.

Authors:  E Anaissie; A Gokaslan; R Hachem; R Rubin; G Griffin; R Robinson; J Sobel; G Bodey
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

Review 10.  Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.

Authors:  S Fournier; W Pavageau; M Feuillhade; S Deplus; A-M Zagdanski; O Verola; H Dombret; J M Molina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-11-01       Impact factor: 3.267
  10 in total
  9 in total

1.  In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.

Authors:  Lin Cong; Yong Liao; Suteng Yang; Rongya Yang
Journal:  Mycopathologia       Date:  2017-01-31       Impact factor: 2.574

2.  Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.

Authors:  I Ramírez; D Moncada
Journal:  Mycopathologia       Date:  2019-12-18       Impact factor: 2.574

3.  Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.

Authors:  Saad J Taj-Aldeen; Nasser Al-Ansari; Sittana El Shafei; Jacques F Meis; Ilse Curfs-Breuker; Bart Theelen; Teun Boekhout
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

Review 4.  Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.

Authors:  Carsten Schwarz; Dominik Hartl; Olaf Eickmeier; Andreas Hector; Christian Benden; Isabelle Durieu; Amparo Sole; Silvia Gartner; Carlos E Milla; Peter James Barry
Journal:  Mycopathologia       Date:  2017-07-31       Impact factor: 2.574

5.  Successful treatment of breakthrough disseminated Trichosporon asahii fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis.

Authors:  Daiki Karigane; Masatoshi Sakurai; Emiko Matsuyama; Kentaro Ide; Sakiko Yamamoto-Takeuchi; Toyoko Inazumi; Sumiko Kohashi
Journal:  Med Mycol Case Rep       Date:  2017-11-28

Review 6.  Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

Authors:  João N de Almeida Júnior; Christophe Hennequin
Journal:  Front Microbiol       Date:  2016-10-17       Impact factor: 5.640

7.  Detection of invasive Trichosporon asahii in patient blood by a fungal PCR array.

Authors:  Jasmin K Weber; Sebastian Scharf; Grit Walther; Greta Flüh; Colin R MacKenzie; Mustafa Kondakci; Birgit Henrich; Malte Kohns Vasconcelos
Journal:  Access Microbiol       Date:  2021-12-03

8.  Genetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patients.

Authors:  Rosana Bellan de Oliveira Silva; Ana Marisa Fusco-Almeida; Marcelo Teruyuki Matsumoto; Lilian Cristiane Baeza; Tatiane Benaducci; Maria José Soares Mendes-Giannini
Journal:  Braz J Microbiol       Date:  2008-09-01       Impact factor: 2.476

9.  Catheter-Related Trichosporon asahii Bloodstream Infection in a Neutropenic Patient with Myelodysplastic Syndrome.

Authors:  Se Eun Go; Kyung Jin Lee; Yaeni Kim; Jae Ki Choi; Yoo Jin Kim; Dong Gun Lee
Journal:  Infect Chemother       Date:  2018-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.